ClinicalTrials.Veeva

Menu

Exercise-induced High-sensitivity Troponin Levels as a Predictor for Obstructive Coronary Artery Disease (EUROCAD)

U

Universitaire Ziekenhuizen KU Leuven

Status

Unknown

Conditions

Coronary Artery Disease

Study type

Observational

Funder types

Other

Identifiers

NCT02626806
UZL9281

Details and patient eligibility

About

  1. To compare hs-TnT levels after a cardiac stress test in patients with vs. patients without CAD
  2. To assess the level of post-exercise hs-TnT predicting CAD (using ROC-analysis)
  3. To determine the sensitivity, specificity and accuracy of this exercise-induced hsTopT level in predicting CAD, either alone or in relation to traditional patient-related and exercise test-related metrics

Enrollment

150 estimated patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients with suspected CAD, planned for diagnostic coronary angiogram
  2. Patients with previous revascularization, suspected of recurrent ischemia

Exclusion criteria

  1. Congestive cardiomyopathy with LV EF < 35%
  2. Renal failure with eGFR < 30 ml/min
  3. Known structural or severe valvular heart disease
  4. Prior CABG
  5. Previous ACS < 6 weeks
  6. Known incomplete revascularization after previous PCI
  7. Unstable angina or ACS (defined as unstable anginal symptoms + ECG changes or hs-TnT > 0.053 ng/L)

Trial design

150 participants in 2 patient groups

patients with hemodynamic significant CAD;
patients without hemodynamic significant CAD

Trial contacts and locations

1

Loading...

Central trial contact

Dries De Cock, MD; Nick Hiltrop, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems